IQVIA (IQV) Competitors $179.98 +1.03 (+0.58%) Closing price 03:59 PM EasternExtended Trading$179.50 -0.49 (-0.27%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IQV vs. BRKR, ICLR, MEDP, TECH, A, CRL, DHR, MTD, TMO, and WATShould you be buying IQVIA stock or one of its competitors? The main competitors of IQVIA include Bruker (BRKR), Icon (ICLR), Medpace (MEDP), Bio-Techne (TECH), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), and Waters (WAT). IQVIA vs. Its Competitors Bruker Icon Medpace Bio-Techne Agilent Technologies Charles River Laboratories International Danaher Mettler-Toledo International Thermo Fisher Scientific Waters Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations. Which has higher earnings & valuation, BRKR or IQV? IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.37$113.10M$0.5258.52IQVIA$15.41B1.99$1.37B$6.9126.05 Do analysts recommend BRKR or IQV? Bruker presently has a consensus target price of $51.30, indicating a potential upside of 68.58%. IQVIA has a consensus target price of $228.62, indicating a potential upside of 27.02%. Given Bruker's higher probable upside, analysts clearly believe Bruker is more favorable than IQVIA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45IQVIA 0 Sell rating(s) 6 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.74 Is BRKR or IQV more profitable? IQVIA has a net margin of 7.88% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 30.05% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 17.89% 5.38% IQVIA 7.88%30.05%6.77% Does the media refer more to BRKR or IQV? In the previous week, Bruker had 36 more articles in the media than IQVIA. MarketBeat recorded 62 mentions for Bruker and 26 mentions for IQVIA. IQVIA's average media sentiment score of 1.48 beat Bruker's score of -0.06 indicating that IQVIA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 10 Very Positive mention(s) 8 Positive mention(s) 17 Neutral mention(s) 12 Negative mention(s) 3 Very Negative mention(s) Neutral IQVIA 24 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, BRKR or IQV? Bruker has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Do insiders & institutionals have more ownership in BRKR or IQV? 79.5% of Bruker shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 27.3% of Bruker shares are owned by company insiders. Comparatively, 1.6% of IQVIA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryIQVIA beats Bruker on 12 of the 16 factors compared between the two stocks. Get IQVIA News Delivered to You Automatically Sign up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IQV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQV vs. The Competition Export to ExcelMetricIQVIAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$30.42B$6.77B$5.44B$20.70BDividend YieldN/A1.35%4.61%3.67%P/E Ratio26.0517.1521.9726.16Price / Sales1.9959.94449.4856.10Price / Cash10.7720.7036.4223.21Price / Book5.295.638.184.33Net Income$1.37B$178.18M$3.26B$996.14M7 Day Performance-1.35%0.14%1.15%1.93%1 Month Performance9.29%-4.82%2.82%-0.54%1 Year Performance-23.76%7.38%28.41%14.79% IQVIA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQVIQVIA4.9016 of 5 stars$179.98+0.6%$228.62+27.0%-22.0%$30.42B$15.41B26.0588,000Positive NewsBRKRBruker4.9326 of 5 stars$34.72-8.6%$53.60+54.4%-48.3%$5.26B$3.37B66.7711,396Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeICLRIcon4.5453 of 5 stars$164.80-1.0%$219.54+33.2%-48.5%$13.31B$8.09B16.9541,900MEDPMedpace4.3492 of 5 stars$432.43+2.2%$406.60-6.0%+16.5%$12.15B$2.11B32.155,900Positive NewsTECHBio-Techne4.9149 of 5 stars$54.880.0%$69.58+26.8%-29.3%$8.60B$1.16B66.933,100Earnings ReportDividend AnnouncementAnalyst ForecastAAgilent Technologies4.6863 of 5 stars$114.99+1.3%$139.77+21.5%-15.0%$32.67B$6.63B28.3917,900Positive NewsCRLCharles River Laboratories International4.6405 of 5 stars$167.74+0.5%$174.54+4.1%-25.1%$8.24B$4.02B-258.0620,100Trending NewsEarnings ReportAnalyst ForecastDHRDanaher4.8528 of 5 stars$197.50+0.2%$247.61+25.4%-24.6%$141.42B$23.88B42.0263,000Positive NewsMTDMettler-Toledo International3.7441 of 5 stars$1,230.69+2.8%$1,300.00+5.6%-9.0%$25.57B$3.87B31.1617,300TMOThermo Fisher Scientific4.9919 of 5 stars$467.41+0.9%$593.00+26.9%-22.5%$176.44B$42.88B27.03125,000Positive NewsInsider TradeWATWaters4.632 of 5 stars$285.97-1.5%$382.40+33.7%-13.7%$17.02B$2.96B25.957,600Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Bruker Alternatives Icon Alternatives Medpace Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Charles River Laboratories International Alternatives Danaher Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IQV) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IQV Stock Alerts